Skip to main content
. 2019 Nov 15;7:e8067. doi: 10.7717/peerj.8067

Table 1. The characteristics of patients.

Clinicopathologic variables n (%) Clinicopathologic variables n (%)
Age (years) Nervous infiltration
≤ 50 79 (46.7) Yes 32 (18.9)
>50 90 (53.3) No 81 (47.9)
Tumor size Unknown 56 (33.2)
≤ 2 cm 59 (34.9) ER
>2 cm 109 (64.5) Positive 108 (63.9)
Unknown 1 (0.6) Negative 60 (35.5)
Lymph node Unknown 1 (0.6)
metastasis PR
Yes 90 (53.3) Positive 100 (59.1)
No 76 (45.0) Negative 68 (40.2)
Unknown 3 (1.7) Unknown 1 (0.7)
stage Ki-67
I 34 (20.1) ≤14% 35 (20.7)
II 87 (51.5) >14% 129 (76.3)
III 44 (26.0) Unknown 5 (3.0)
Unknown 4 (2.4) Her-2
Histological grade Positive 36 (21.3)
I ∼ II 88 (52.1) Negative 95 (56.2)
III 62 (36.7) Unknown 38 (22.5)
Unknown 19 (11.2) Molecular subtype
Vascular invasion Luminal A 16 (9.5)
Yes 67 (39.6) Luminal B 93 (55.0)
No 60 (35.5) HER-2
Unknown 42 (24.9) overexpression 17 (10.1)
Lymphatic vessel TNBC 24 (14.2)
invasion Unknown 19 (11.2)
Yes 51 (30.1)
No 64 (37.9)
Unknown 54 (32.0)